Getein Biotech (SHSE:603387) E10: ¥0.61 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603387 Getein Biotech Inc SHSE:603387
77 GF Score
Price ¥8.94
GF Value ¥7.57
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Getein Biotech E10?

Getein Biotech SHSE:603387 +0.45% 77 E10 is ¥0.61 as of Mar. 2026. GuruFocus rates SHSE:603387 with a GF Score™ of 77/100 and a GF Value™ of ¥7.57 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Getein Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.61 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Getein Biotech's average E10 Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-02), Getein Biotech's current stock price is ¥8.94. Getein Biotech's E10 for the quarter that ended in Mar. 2026 was ¥0.61. Getein Biotech's Shiller PE Ratio of today is 14.66.

During the past 13 years, the highest Shiller PE Ratio of Getein Biotech was 16.70. The lowest was 12.33. And the median was 13.97.


Getein Biotech  (SHSE:603387) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Getein Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.94/0.61
=14.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Getein Biotech was 16.70. The lowest was 12.33. And the median was 13.97.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Getein Biotech E10 Related Terms


Getein Biotech E10 Historical Data

* Premium members only.

The historical data trend for Getein Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getein Biotech E10 Chart

Getein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.60 0.60

Getein Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.60 0.60 0.60 0.61

SHSE:603387 vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Getein Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getein Biotech Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getein Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Getein Biotech's Shiller PE Ratio falls into.


SHSE:603387
77GF Score
Getein Biotech Inc SHSE:603387
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Getein Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Getein Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.15/116.3033*116.3033
=0.150

Current CPI (Mar. 2026) = 116.3033.

Getein Biotech Quarterly Data

per share eps CPI Adj_EPS
201606 0.090 101.400 0.103
201609 0.086 102.400 0.098
201612 0.112 102.600 0.127
201703 0.107 103.200 0.121
201706 0.130 103.100 0.147
201709 0.102 104.100 0.114
201712 0.109 104.500 0.121
201803 0.131 105.300 0.145
201806 0.124 104.900 0.137
201809 0.138 106.600 0.151
201812 0.133 106.500 0.145
201903 0.167 107.700 0.180
201906 0.135 107.700 0.146
201909 0.087 109.800 0.092
201912 0.276 111.200 0.289
202003 0.061 112.300 0.063
202006 0.103 110.400 0.109
202009 0.194 111.700 0.202
202012 0.214 111.500 0.223
202103 0.121 112.662 0.125
202106 0.219 111.769 0.228
202109 0.160 112.215 0.166
202112 0.280 113.108 0.288
202203 0.430 114.335 0.437
202206 0.220 114.558 0.223
202209 0.280 115.339 0.282
202212 0.050 115.116 0.051
202303 0.240 115.116 0.242
202306 0.090 114.558 0.091
202309 0.120 115.339 0.121
202312 0.100 114.781 0.101
202403 0.170 115.227 0.172
202406 0.120 114.781 0.122
202409 0.060 115.785 0.060
202412 0.090 114.893 0.091
202503 0.130 115.116 0.131
202506 0.080 114.907 0.081
202509 0.110 115.471 0.111
202512 0.120 115.832 0.120
202603 0.150 116.303 0.150

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.61 mean?
Getein Biotech (SHSE:603387) has a E10 of ¥0.61 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Getein Biotech and its competitors.
Is Getein Biotech's E10 too high?
Getein Biotech's current E10 is ¥0.61. Overall, Getein Biotech has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getein Biotech's E10 compare to ABT and SYK?
Getein Biotech's E10 of ¥0.61 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Getein Biotech and its competitors. Getein Biotech's current E10 is ¥0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Getein Biotech (SHSE:603387) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥7.57, compared to a current price of ¥8.94 — trading 18.1% above its estimated fair value. The current E10 is ¥0.61. Getein Biotech's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Getein Biotech (SHSE:603387), the current E10 is ¥0.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Getein Biotech (SHSE:603387) Overvalued in 2026?

Based on GuruFocus' analysis, Getein Biotech stock appears to be overvalued. The current stock price of ¥8.94 is trading 18.1% above its estimated GF Value™ of ¥7.57. GuruFocus considers Getein Biotech to be Modestly Overvalued.

Key valuation signals for SHSE:603387:

  • E10: ¥0.61
  • GF Value™: ¥7.57 vs. price of ¥8.94 (18.1% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603387 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Getein Biotech Business Description

Address No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
77GF Score

Get the complete analysis for SHSE:603387

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.94
Price
¥7.57
GF Value